Acetazolamide Extended-Release Tablets Should Not Be Crushed
Acetazolamide extended-release (ER) formulations should never be crushed, as this destroys the sustained-release mechanism and can result in immediate release of the entire dose, leading to potential overdose and loss of therapeutic effect. 1, 2
Why Crushing ER Acetazolamide Is Dangerous
Crushing modified-release tablets fundamentally alters drug pharmacokinetics by destroying the controlled-release matrix, resulting in immediate release of the full dose rather than gradual absorption over time 1
This practice can cause serious clinical consequences including fatal overdose from rapid drug absorption or underdosing when the active ingredient degrades upon exposure 2
Research on metoprolol succinate ER tablets demonstrated that crushing changes dissolution profiles across all gastrointestinal pH ranges, with significant differences in drug release patterns and particle morphology 1
The person crushing tablets faces occupational exposure to drug particles that may be carcinogenic, teratogenic, or allergenic 2
Appropriate Alternatives
Immediate-Release Acetazolamide Tablets
The best alternative is to switch to immediate-release acetazolamide tablets, which can be crushed if necessary 3, 4
Immediate-release acetazolamide 25 mg/mL suspension prepared from crushed tablets remains stable for at least 79 days when stored at room temperature in amber glass bottles at pH 4-5 3
The suspension can be prepared by crushing immediate-release 250 mg tablets and mixing with appropriate vehicles containing sorbitol, magnesium aluminum silicate, and carboxymethylcellulose sodium 3
Injectable Formulation
Parenteral acetazolamide is available for patients who cannot take oral medications 5
Each 500 mg vial should be reconstituted with at least 5 mL of sterile water for injection 5
The direct intravenous route is preferred; intramuscular administration is not recommended 5
Reconstituted solutions retain stability for 3 days under refrigeration (2-8°C) or 12 hours at room temperature 5
Dosing Considerations When Switching
For glaucoma treatment, acetazolamide dosing ranges from 250 mg to 1 g per 24 hours in divided doses, with amounts over 1 g per day typically not producing increased therapeutic effect 5
For epilepsy, the optimal range is 375-1000 mg daily in divided doses, though some patients respond to lower doses 5
Critical Safety Points
Before crushing any medication, assess whether the tablet is immediate-release or extended-release 2, 6, 4
A coordinated care team approach involving physicians, pharmacists, nurses, and speech therapists is necessary to develop individualized medication administration plans for patients with dysphagia 6
Monitor patients closely when switching formulations as bioavailability and pharmacokinetic profiles may differ between crushed immediate-release tablets and intact ER formulations 1, 6